Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction to Fibroblasts01:09

Introduction to Fibroblasts

3.2K
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New and emerging entities of uterine mesenchymal tumours in the era of molecular testing.

Polish journal of pathology : official journal of the Polish Society of Pathologists·2026
Same author

High-grade endometrial stromal sarcoma heterogeneity: Fusion-driven, fusion-negative, and related undifferentiated uterine sarcomas.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Correction: Cold microwave plasma jets for wound healing: antimicrobial efficacy, mechanisms and changes in microbial cells.

Scientific reports·2026
Same author

Immunohistochemistry for p16 and p53 Provides Substantial Agreement With Molecular Tests in Penile Cancer.

Pathology international·2026
Same author

Clinically Silent Local Recurrence of Breast Cancer Detected in a Mastectomy Scar During DIEP Flap Reconstruction: A Case Report.

Clinical case reports·2026
Same author

Prognostic impact of p53 and HER2 immunohistochemistry profiles in colorectal carcinoma.

Pathology oncology research : POR·2026

Related Experiment Video

Updated: Aug 26, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.3K

Giant cell fibroblastoma: a case report.

Jan Hrudka, Jan Hojný, Eva Leamerová

    Ceskoslovenska Patologie
    |October 12, 2022
    PubMed
    Summary

    Giant cell fibroblastoma, a rare locally aggressive tumor, can be mistaken for dermatofibrosarcoma protuberans (DFSP). Confirmation relies on identifying the COL1A1-PDGFB gene fusion, crucial for accurate diagnosis and treatment.

    Area of Science:

    • Oncology
    • Pathology
    • Genetics

    Background:

    • Giant cell fibroblastoma (GCF) is a rare, locally aggressive mesenchymal tumor affecting young individuals, primarily on the trunk.
    • GCF shares similarities with dermatofibrosarcoma protuberans (DFSP), including morphology, immunophenotype, and the COL1A1-PDGFB gene fusion, suggesting a potential relationship.
    • Local recurrence is common in GCF if incompletely excised, but distant metastasis is not observed.

    Observation:

    • A case report details a young man with a slowly growing subcutaneous groin tumor.
    • Histological examination revealed a mesenchymal tumor with multinucleated giant cells and pleomorphic spindle cells.
    • Immunohistochemistry showed CD34 positivity in tumor cells and ERG positivity in endothelial cells.

    Findings:

    Keywords:
    dermatofibrosarcoma protuberansfibroblastomagiant celljuvenile

    More Related Videos

    Experimental Generation of Carcinoma-Associated Fibroblasts CAFs from Human Mammary Fibroblasts
    15:43

    Experimental Generation of Carcinoma-Associated Fibroblasts CAFs from Human Mammary Fibroblasts

    Published on: October 25, 2011

    23.5K
    Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
    09:06

    Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

    Published on: November 11, 2021

    2.6K

    Related Experiment Videos

    Last Updated: Aug 26, 2025

    An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
    06:35

    An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

    Published on: February 8, 2019

    7.3K
    Experimental Generation of Carcinoma-Associated Fibroblasts CAFs from Human Mammary Fibroblasts
    15:43

    Experimental Generation of Carcinoma-Associated Fibroblasts CAFs from Human Mammary Fibroblasts

    Published on: October 25, 2011

    23.5K
    Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
    09:06

    Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

    Published on: November 11, 2021

    2.6K
  • The presence of multinucleated giant cells and specific immunoprofile raised suspicion for GCF.
  • Molecular analysis confirmed the diagnosis by identifying the COL1A1-PDGFB gene fusion.
  • Positive surgical margins necessitated a reexcision, highlighting the tumor's borderline malignant behavior.
  • Implications:

    • Accurate diagnosis of GCF is crucial due to its potential for local recurrence.
    • Understanding the link between GCF and DFSP, including the shared COL1A1-PDGFB gene fusion, aids in diagnosis and management.
    • This case underscores the importance of molecular confirmation for rare tumors like GCF.